This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002, as well as the first transcatheter mitral commissurotomy in 1995 and the first balloon aortic valvuloplasty in 1986. He passed away Feb. 16, 2024 at the age of 79.
Resource SAVR After TAVR Risk Calculator kchalko Fri, 04/12/2024 - 13:53 SAVR after previous TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority of patients require explant of their TAVR device and SAVR with significantly increased risk of operative mortality and stroke.
Featuring numerous abstracts with fresh insights into health disparities, efficacy data for TAVR, and innovative strategies for PAD, we eagerly anticipate the convergence of professionals from diverse specialties. About 276,000 patients have undergone a TAVR procedure in the United States.
The event’s late-breaking trial sessions focus on studies anticipated to significantly influence advances in cardiothoracic patientcare. Using the Society of Thoracic Surgeons Adult Cardiac Surgery Database , the study covers adult patients who underwent cardiac surgery after an initial TAVR from January 2012 to March 2023.
Not only does this result in a cumbersome and inefficient workflow, as cardiologists must bounce between systems and locations to retrieve and compare relevant prior and current multi-modality information, it can also result in critical information gaps that have a direct, negative impact on patientcare and outcomes.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24
When providers and clinicians have access to the best quality data, patientcare improves. The Society’s mission is to advance cardiothoracic surgeons’ delivery of the highest quality patientcare through collaboration, education, research, and advocacy. Legislation that improves data flow helps all parties."
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content